Open-label treatment with duloxetine hydrochloride once-daily dosing for evaluation of stabilization dose in patients with major depression
Phase of Trial: Phase III
Latest Information Update: 24 Aug 2007
At a glance
- Drugs Duloxetine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 24 Aug 2007 The expected completion date for this trial is now 1 Dec 2003.
- 15 Jun 2006 New trial record.